SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 91 filers reported holding SURFACE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $754 | +2.9% | 868,620 | -17.4% | 0.00% | 0.0% |
| Q1 2023 | $733 | -18.0% | 1,051,718 | -3.7% | 0.00% | -25.0% |
| Q4 2022 | $894 | -99.9% | 1,092,356 | +21.3% | 0.00% | -20.0% |
| Q3 2022 | $936,000 | +74.3% | 900,829 | +175.0% | 0.01% | +66.7% |
| Q2 2022 | $537,000 | -16.9% | 327,610 | +48.8% | 0.00% | 0.0% |
| Q1 2022 | $646,000 | -17.0% | 220,227 | +34.9% | 0.00% | 0.0% |
| Q4 2021 | $778,000 | -82.8% | 163,214 | -71.8% | 0.00% | -83.3% |
| Q1 2021 | $4,522,000 | +17.6% | 579,677 | +39.3% | 0.02% | +20.0% |
| Q4 2020 | $3,844,000 | +41.3% | 416,095 | +5.5% | 0.02% | +36.4% |
| Q3 2020 | $2,720,000 | +67.9% | 394,232 | +59.7% | 0.01% | +57.1% |
| Q2 2020 | $1,620,000 | +545.4% | 246,923 | +84.8% | 0.01% | +600.0% |
| Q1 2020 | $251,000 | +24.9% | 133,643 | +25.1% | 0.00% | 0.0% |
| Q4 2019 | $201,000 | +33.1% | 106,841 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $151,000 | -46.6% | 106,841 | +6.7% | 0.00% | 0.0% |
| Q2 2019 | $283,000 | -35.8% | 100,120 | +8.3% | 0.00% | -50.0% |
| Q1 2019 | $441,000 | +687.5% | 92,480 | +593.8% | 0.00% | – |
| Q4 2018 | $56,000 | – | 13,329 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $22,297,000 | 7.41% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,291,000 | 0.67% |
| SummerHaven Investment Management, LLC | 128,078 | $970,000 | 0.57% |
| Parkman Healthcare Partners LLC | 248,267 | $1,879,000 | 0.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $379,000 | 0.21% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $250,000 | 0.17% |
| ARK Investment Management | 4,618,354 | $34,961,000 | 0.08% |
| Knights of Columbus Asset Advisors LLC | 114,594 | $867,000 | 0.08% |
| Orbimed Advisors | 909,666 | $6,886,000 | 0.08% |
| HighVista Strategies LLC | 13,932 | $105,000 | 0.07% |